GSK touts wearables for clinical trials; AbbVie buys out an Asian contractor;

> GlaxoSmithKline ($GSK) and partner Medidata ($MDSO) took a look at millions of data points collected from wearable devices and determined that mHealth technology can generate clinically relevant patient information. News

> AbbVie ($ABBV) has bought out a Singapore manufacturer and landed its first plant in Asia. Story

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.